Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Oxytocin

Pitocin, Syntocinon

Quick Stats
Studies 93
Trials 100
Completed PHASE1 INTERVENTIONAL NCT00263796

An fMRI Study of the Effect of Intravenous Oxytocin vs. Placebo on Response Inhibition and Face Processing in Autism

View on ClinicalTrials.gov Updated Dec 15, 2025

Brief Summary

To study the effect of oxytocin on face processing and response inhibition in autistic adults by fMRI.

Detailed Description

Autism is a developmental disorder affecting approximately 60/10,000 individuals. It is characterized by social and language deficits and repetitive behaviors/restricted interests. Functional imaging is becoming a very useful tool in trying to understand the neurobiology of autism. Oxytocin is a hormone produced by the brain to assist with labor and lactation. Recent evidence suggests that it may be involved in social attachment and in repetitive behaviors. In this project, we will study how oxytocin changes the way the brain of autistic adults processes faces, and deals with response inhibition (the ability to interrupt ongoing responses should they prove ineffective or interfering with attaining a goal). There is currently no functional imaging data assessing the effect of oxytocin on the brain. We will explore the activation patterns in response to oxytocin across circuits involved in social cognition (face fusiform area) and response inhibition (caudate, orbitofrontal and dorsolateral cortex) by administering a specific fMRI task activating those circuits before and during an oxytocin infusion. We will also explore the effect of oxytocin in these areas by administering specific cognitive testing not associated with fMRI before and during oxytocin infusion.

Interventions

Name: Oxytocin
Type: DRUG
Description: 10 international units = 1 cc, IV over 4 hours
Name: Placebo
Type: DRUG
Description: Normal Saline, IV over 4 hours

Primary Outcomes

Measure: Change in BOLD with oxytocin infusion
TimeFrame: baseline and 4 hours
Description: Change in BOLD with oxytocin infusion BOLD - blood-oxygen-level-dependent contrast

Trial Information

NCT ID

NCT00263796

Status

Completed

Study Type

INTERVENTIONAL

Phases

PHASE1

Sponsor

Anagnostou, Evdokia, M.D.

Last Updated

December 15, 2025